[HTML][HTML] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
J Kim, TW Jang, CM Choi, MH Kim, SY Lee… - Translational Lung …, 2023 - ncbi.nlm.nih.gov
Background Overall survival (OS) in patients with non-small cell lung cancer (NSCLC) and
brain metastases (BMs) is poor. We aimed to identify prognostic factors and ascertain …
brain metastases (BMs) is poor. We aimed to identify prognostic factors and ascertain …